Ad is loading...
MENU

MESO Stock Tickeron detected bullish Stock Pattern: Broadening Wedge Descending MESO on September 30, 2024, netting in a 30.85% gain over 2 months

A.I.dvisor
at Tickeron.com
Loading...
+30.85% Gain from a Successful pattern Broadening Wedge Descending
MESO - Mesoblast Limited
Tickeron
Ticker: MESO
Company: Mesoblast
Gain: +30.85%
Confirmed: 09/30/24
Succeeded: 10/01/24
Total length: 60 days
On August 02, 2024, A.I.dvisor detected a Broadening Wedge Descending Pattern (Bullish) for Mesoblast Limited (MESO, $6.32). On September 30, 2024, A.I.dvisor confirmed the Bullish pattern, setting a target price of $8.52. 1 day later, on October 01, 2024, MESO reached the target price resulting in a +3 for traders who took a long position in the stock.

MESO in +7.77% Uptrend, growing for three consecutive days on November 19, 2024

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MESO advanced for three days, in of 271 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 08, 2024. You may want to consider a long position or call options on MESO as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MESO just turned positive on November 12, 2024. Looking at past instances where MESO's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for MESO moved out of overbought territory on November 15, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 59 cases where MESO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MESO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MESO broke above its upper Bollinger Band on November 11, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MESO entered a downward trend on November 11, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MESO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.403) is normal, around the industry mean (13.849). P/E Ratio (0.000) is within average values for comparable stocks, (88.142). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.810). MESO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (140.845) is also within normal values, averaging (223.470).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MESO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
MESO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in the development and commercialization of biological products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Level 38, 55 Collins Street
Phone
+61 396396036
Employees
83
Web
https://www.mesoblast.com